- Home
- ADCT vs NECB Comparison
ADCT vs NECB Comparison
Compare ADCT & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- NECB
- Stock Information
- Founded
- ADCT 2011
- NECB 1934
- Country
- ADCT Switzerland
- NECB United States
- Employees
- ADCT N/A
- NECB N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- NECB Savings Institutions
- Sector
- ADCT Health Care
- NECB Finance
- Exchange
- ADCT Nasdaq
- NECB Nasdaq
- Market Cap
- ADCT 241.0M
- NECB 281.2M
- IPO Year
- ADCT 2020
- NECB N/A
- Fundamental
- Price
- ADCT $2.69
- NECB $20.18
- Analyst Decision
- ADCT Strong Buy
- NECB
- Analyst Count
- ADCT 6
- NECB 0
- Target Price
- ADCT $7.80
- NECB N/A
- AVG Volume (30 Days)
- ADCT 663.5K
- NECB 37.9K
- Earning Date
- ADCT 08-12-2025
- NECB 07-24-2025
- Dividend Yield
- ADCT N/A
- NECB 3.96%
- EPS Growth
- ADCT N/A
- NECB N/A
- EPS
- ADCT N/A
- NECB 3.29
- Revenue
- ADCT $75,817,000.00
- NECB $103,145,000.00
- Revenue This Year
- ADCT $11.75
- NECB $1.90
- Revenue Next Year
- ADCT $8.56
- NECB $6.93
- P/E Ratio
- ADCT N/A
- NECB $6.13
- Revenue Growth
- ADCT 10.49
- NECB N/A
- 52 Week Low
- ADCT $1.05
- NECB $19.75
- 52 Week High
- ADCT $3.97
- NECB $31.72
- Technical
- Relative Strength Index (RSI)
- ADCT 40.85
- NECB 25.80
- Support Level
- ADCT $2.84
- NECB $22.94
- Resistance Level
- ADCT $3.19
- NECB $22.67
- Average True Range (ATR)
- ADCT 0.19
- NECB 0.72
- MACD
- ADCT -0.06
- NECB -0.35
- Stochastic Oscillator
- ADCT 12.66
- NECB 5.60
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.